The First Results of a Full Loading Dose of Brolucizumab in the Treatment of DME
The aim of the study was to evaluate the efficacy and safety of brolucizumab in the Russian population of patients with diabetic macular edema. Patients and methods: 41 patients (29 women and 12 men) with diabetic retinopathy and diabetic macular edema of comparable age were included in the study. T...
Saved in:
Main Authors: | R. N. Amirkulieva, E. N. Khomyakova, I. A. Loskutov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Ophthalmology Publishing Group
2023-12-01
|
Series: | Oftalʹmologiâ |
Subjects: | |
Online Access: | https://www.ophthalmojournal.com/opht/article/view/2247 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New Drugs for the Treatment of DME and the Role of Biomarkers in Predicting Their Effectiveness
by: M. V. Budzinskaya, et al.
Published: (2023-01-01) -
Experience with Brolucizumab Treatment of Neovascular Age-Related Macular Degeneration
by: M. V. Budzinskaya, et al.
Published: (2023-01-01) -
Short-term Outcomes of Anti-VEGF therapy in Neovascular Age-related Macular Degeneration with Initially Low Visual Acuity
by: A. N. Kulikov, et al.
Published: (2025-03-01) -
ASSOCIATION BETWEEN THE DEGREE OF DIABETIC RETINOPATHY AND DIABETIC MACULAR EDEMA
by: Andhika Guna Dharma, et al.
Published: (2022-01-01) -
Tomographic Parameters of Recurrent Macular Edema Due to Retinal Vein Occlusion during Antiangiogenic Therapy
by: D. Yu. Khokhlova, et al.
Published: (2021-10-01)